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Recent studies (1-4) have shown that anti-Tac monoclonal antibody recognizes 
the  human  receptor  for  interleukin  2  (IL-2),  which  is  expressed  on  plasma 
membrane of T  cells activated by antigens or lectins.  Our  initial experiments 
showed  that  the  expression  of Tac  antigen  was  restricted  predominantly  to 
activated T  cells (1).  In a  murine  system, however,  it was reported  that  IL-2 
receptors were present at low levels on Thy-1-negative spleen cells activated with 
anti-Ig-plus factors when examined by radiolabeled human IL-2 (5).  Moreover, 
very recently Korsmeyer et al. (6) demonstrated the expression of Tac antigen 
in eight cases of hairy cell leukemia that proved to be B cell lineage malignancies, 
suggesting the possibility that IL-2 receptor may be expressed at certain stages 
of normal B cell development. 
In this study, we directly demonstrate the expression of Tac antigen on normal 
human B cells activated with Staphylococcus aureus Cowan I (SAC) by the method 
of two-color fluorescence analysis. In addition, we show here that SAC-activated 
B  cells  proliferate  in  response  to  immunoaffinity-purified IL-2  and  that  the 
proliferative response is completely inhibited by anti-Tac antibody that blocks 
the membrane binding and action of IL-2. We will discuss the possible involve- 
ment of an IL-2 receptor system in the B cell immune response. 
Materials and Methods 
Cell Separations.  Peripheral blood mononuclear cells from normal volunteers were 
isolated by Ficoll-Paque (Pharmacia, Inc., Uppsala, Sweden) density gradient centrifuga- 
tion. To obtain a  B cell-enriched population, T  cells and adherent cells were depleted 
(7). T  cell depletion was accomplished by twice removing by Ficoll-Paque centrifugation 
the cells that rosetted with 2-aminoethylisothiouronium bromide hydrobromide (AET)- 
treated sheep erythrocytes (E). Adherent cells were removed by the adherence to plastic 
dishes for 60 rain at 37°C. The resulting B cell-enriched population, used as B cells, 
contained <0.1%  E-rosetting cells  and  80-90%  surface immunoglobulin (sIg)-positive 
cells, when stained by the fluorescein isothiocyanate (FITC)-conjugated F(ab')z  fraction 
of goat anti-human Ig (Cappel  Laboratories, Cochranviile, PA). T  cell-enriched popula- 
tions, also obtained by twice centrifuging E-rosetting cells through FicolI-Paque, contained 
>95% E-rosetting cells and <1% sIg-positive  cells. 
Cell Activation  with SAC.  B or T  cells (4  ×  106) suspended in 2 ml of RPMI  1640 
medium containing 10% fetal calf serum (FCS) and 30 ~g/ml of gentamycin were cultured 
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with various indicated concentrations of SAC (Immusorbin; Wako Pure Chemical Indus- 
tries, Osaka, Japan) in Falcon 2006 round-bottom tubes for 3 d at 37°C under 5% COs. 
Cultured cells were filtered through meshes (50 t~m pore size) to remove large fragments 
of SAC that might interfere with flow cytofluorometry. 
Anti-Tac Antibody and Detection of Tac Antigen on the Celt Surface.  The IgG fraction of 
the antibody from hybridoma ascites was purified by the gel and DEAE cellulose chro- 
matography. After pepsin digestion, the F(ab')2  fraction was separated by gel filtration 
and protein A-Sepharose (Pharmacia, Inc.) affinity chromatography, followed by conju- 
gation with FITC (Sigma Chemical Co., St.  Louis, MO).  For the direct staining of Tac 
antigen on the cell surface, cells (1 ×  106) were incubated (4 °C, 30 rain) with a saturating 
concentration (10 #g/ml) of FITC-conjugated F(ab')~ fraction of anti-Tac antibody (FITC- 
anti-Tac), and washed twice with Hanks' balanced salt solution containing I  mg/ml of 
bovine serum albumin (BSA) and 0.1% sodium azide. All samples were analyzed by flow 
cytofluorometry (Spectrum III; Ortho Diagnostic Systems, Westwood, MA). 
Two-Color Fluorescence Analysis (8).  SAC-activated B cells were simultaneously stained 
with anti-Tac and anti-human Ig. B cells (1 ×  106) were sequentially incubated at 4°C for 
30 rain (with thorough washing after each reagent) with 10 #g]ml of anti-Tac IgG, 10 
#g/ml of biotinyl horse anti-mouse IgG (Vecter Laboratories, Inc., Burlingame, CA), 5 #1 
ofphycoerythrin (PE)-conjugated avidin (Avidin PE; Becton Dickinson Monoclonal Center 
Inc., Mountain View, CA), and FITC-anti-human Ig. Samples were passed on Spectrum 
III using an argon ion laser at 488 nm excitation wavelength. Green fluorescence (515- 
530 nm wavelength) from FITC, and red (>630 nm) from PE were detected independently 
and displayed as dot plots in the logarithmic scale of fluorescence intensity. 
Assay for B Cell Proliferation.  IL-2, purified from culture supernatants of Jurkat cell 
line by an affinity column coupled with anti-IL-2 monoclonal antibody, was generously 
provided by Dr. K. A. Smith (9). B cell proliferation induced by IL-2 was determined by 
the method of Muraguchi and Fauci (7). Briefly, SAC-activated B celt blasts were prepared 
by culturing resting B cells (2 ×  106/ml) with SAC (10  -4 vol/vol) for 3 d. These blasts (5 
×  104) in  200  #1  of medium were cultured with a  twofold dilution series of IL-2  in 
triplicate in a 96-well plate. B cell proliferation, as indicated by the incorporation of 0.5 
#Ci/well of [3H]thymidine (2 Ci/mol; Amersham Japan, Tokyo), was measured during the 
last  16 h of a  72-h culture. In the experiments of the inhibition of IL-2-induced B cell 
proliferation  by anti-Tac antibody,  the  antibody (10-10 -s  #g/ml)  was  added  to  the 
triplicated cultures of SAC-activated B cell blasts (5 ×  104/well) plus 0.5 U/ml of IL-2. 
The percent inhibition was calculated by the following formula: Percent inhibition =  100 
×  [1  -  (cpm experimental -  cpm medium control)/(cpm IL-2 control -  cpm medium 
control)], where medium control is the culture with medium alone (3,069 _+ 42 cpm) and 
IL-2 control is 12,443  _+ 592 cpm. 
Results and Discussion 
Tac Expression of Activated Normal B  Cells.  To examine whether Tac antigen 
is  expressed  on activated  B  cells, freshly separated  B  cells (2  ×  106/ml)  were 
cultured  for  3  d  with  SAC,  a  B  cell  mitogen  (7),  at  various  concentrations. 
Cultured B cells were stained with FITC-conjugated F(ab')2 fraction of anti-Tac 
antibody to avoid the binding of anti-Tac to B cells via Fc receptors.  As shown 
in Table I, the expression of Tac antigen was clearly observed on B cells activated 
by SAC at >10 -4  concentration (vol/vol), when analyzed by Spectrum  III.  In 
contrast, B cells cultured with medium alone did not express Tac antigen. Fig. 
1A  shows  the  representative  fluorescence pattern  of Tac  antigen  on  B  cells 
activated by  10 -4 (vol/vol) of SAC, indicating the wide distribution of fluores- 
cence intensity. Under the same conditions, however,  normal T  cells were not 
stimulated by SAC to express Tac antigen (<1%) (Fig.  1 B). 014  TSUDO  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Expression of Tac Antigen on SAC-activated B Cells 
Tac  ÷ Cells 
Cultured with:  (mean -+ SEM, n = 5) 
% 
Medium alone  1.5 +-- 0.5 
SAC 10 -~ (vol/vol)  22.7 + 6.2 
10  -4  19.2 -+ 1,5 
10  -~  3.7 +  1,0 
10 -6  3,2 -.-+ 0.8 
B cells were  cultured  with  SAC for 3 d,  then stained  with the  FlTC-conjugated 
F(ab')~ fraction  ofanti-Tac antibody. 
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FICURE  1.  The fluorescence profile of Tac antigen on SAC-activated B cells (A) and T  cells 
(B).  Cells  were cultured  with  SAC  (10 -4  vol/vol) for  3  d,  stained  by  the  FITC-conjugated 
F(ab')2 fraction of anti-Tac antibody, and analyzed by the Spectrum l l] (linear scale).  Dotted 
fines are nonstaining controls. 
Two-color Fluorescence Analysis.  Although  T  cell contamination  in the B cell 
population  was  <0.1%,  we  performed  two-color  fluorescence  analysis  (8)  to 
confirm that Tac antigen  was expressed exactly on B cells, but not on T  cells or 
non-T non-B cells. SAC-activated B cells were sequentially stained with anti-Tac, 
biotinyl  anti-mouse  IgG,  and  PE-conjugated  avidin,  followed by staining  with 
FITC  anti-human  Ig.  Green  fluorescence  from  FITC  and  red  from  PE  were 
independently  detected  by  Spectrum  IlI  and  displayed  as  dot  plots.  Fig.  2D 
clearly shows that  Tac-expressing cells were included  in  the population  of sIg- 
bearing cells. Fig. 2, A, B, and C shows the controls of nonstaining, single staining 
of Tac antigen, and single-staining of sIg, respectively. 
An urgent question was then whether IL-2 generates any immune response of 
B cells by binding  to Tac antigen/IL-2  receptor.  We studied  the  proliferative 
response of SAC-activated B cells to affinity-purified IL-2. B cell blasts (5 x  104/ 
well) activated by SAC for 3 d  were cultured with serial dilutions of IL-2, and 
the proliferation  of cells was determined after an additional  3 d  of culture (7). 
As  shown  in  Fig.  3A,  SAC-activated  B  cells  proliferated  dose dependently  in 
response  to  IL-2.  In  contrast,  freshly separated  B cells,  which did  not express 
Tac antigen,  showed no detectable proliferation  when cultured with IL-2 for 3 
d, suggesting that  the prior activation  was required  for IL-2-induced prolifera- 
tion.  These  results  are  very  similar  to  observations  in  IL-2-induced  T  cell 
proliferation  (4).  Expecting  to  find  that  ]L-2-induced  B  cell  proliferation  is 
inhibited by anti-Tac antibody blocking the membrane binding and action of IL- TSUDO  ET  AL.  BRIEF  DEFINITIVE  REPORT  615 
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FIGURE 2+  Two-color fluorescence analysis of SAC-activated  B cells.  (D) Both Tac antigen 
and slg were stained as described  in Materials and Methods.  Tac  ÷ cells were included in the 
slg  + population.  (A) Nonstaining control. (B and C) Controls  of the single staining of Tac 
antigen and slg, respectively. 
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FIGURE 3.  (A) Proliferative  response of B cells to IL-2. SAC-activated B cells (5 x  104/well) 
(O) proliferated  in response to IL-2, dose dependently, whereas freshly separated B cells (5 x 
104/well) (Q) showed no detectable  proliferation.  Data represent the mean ± SEM of triplicate 
cultures.  (B) The inhibition of IL-2-induced  B cell proliferation  by anti-Tac  antibody.  SAC- 
activated  B cells  (5  ×  104/well)  were cultured in triplicate  with  0.5  U/ml of IL-2  in the 
presence of anti+Tac (O) or control IgG (0) from MPC11 mouse myeloma cells. Data represent 
the percent inhibition of [3H]thymidine incorporation. 
2 in the T  cell system, we cultured SAC-activated  B  cells with 0.5 U/ml of IL-2 
in the presense of anti-Tac  or control  mouse  myeloma (MPC1 1) ]gG at various 
concentrations, as described in Materials and Methods.  As shown in Fig. 3B, IL- 
2-induced B  cell proliferation  was remarkably inhibited by anti-Tac at very  low 
concentrations.  Similar  inhibition  was  also  observed in  the  experiments  using 616  TSUDO  ET AL  BRIEF  DEFINITIVE REPORT 
F(ab')2 fragments ofanti-Tac, indicating that the inhibition was not Fc receptor- 
mediated suppression. 
A simple and reasonable explanation for our results may be that Tac antigen 
on SAC-activated B cells is the functioning IL-2 receptor, and that these B cells 
proliferate directly in response to IL-2. However, it is still controversial whether 
IL-2 is involved in B cell growth and/or differentiation.  Some investigators (10, 
11) have suggested that  IL-2 itself plays an important role in the B cell growth, 
while Howard et al. (12) reported the possibility that  IL-2 stimulates T  cells to 
release, in turn, a B cell growth factor (BCGF) distinct from IL-2 which facilitates 
the  proliferation  of B  cells.  However,  it  is  unlikely  that  in  our  experimental 
system the target cells of IL-2 were T  cells and not SAC-activated, Tac-bearing 
B cells for the following reasons. First, the contamination of T  cells in the SAC- 
activated B cell population  was negligible (<0.5%) when  examined by staining 
with FITC-OKT3 (data not shown). Second, the residual T  cells, if any, did not 
express Tac antigen/IL-2  receptor when  stimulated  by SAC (Fig.  1 B). Collec- 
tively, the data strongly suggest that  IL-2 acts directly on SAC-activated B cells 
through the Tac antigen/IL-2 receptor. Tac antigen was not noted in our initial 
studies (1) on B cells activated with pokeweed mitogen (PWM) or Epstein-Barr 
virus,  as  measured  by complement-dependent  cytotoxity. Our  preliminary  ex- 
periments,  however,  showed  that  a  proportion  of B  cells in  peripheral  blood 
mononuclear cells activated with  PWM expressed Tac antigen  weakly but dis- 
tinctly,  when  examined  by the  more sensitive cytofluorometry after two-color 
staining (data not shown). Considering that anti-Tac at very low concentrations 
remarkably suppressed T  cell-dependent B cell Ig production by PWM (13 and 
our unpublished data),  the target  cells of anti-Tac  may be not only T  cells but 
also B cells. 
The mechanism of B cell growth and differentiation seems to be a complicated 
one in which many factors participate.  Our studies indicate that an IL-2 receptor 
system also appears to be involved in B cell immunity. 
Summary 
Two-color fluorescence analysis revealed that  Tac antigen,  which was previ- 
ously reported  to  be  restricted  to  T  cells,  was  expressed  on  a  proportion  of 
normal B cells activated by Staphylococcus aureus Cowan I (SAC). Immunoaffinity- 
purified interleukin  2 (IL-2) induced the proliferation of SAC-activated B cells, 
and  the  proliferation  was  completely  inhibited  by  anti-Tac  antibody,  which 
blocked the membrane binding and action of IL-2. These results suggest that an 
IL-2 receptor system is directly involved in the B cell immune response. 
We  thank  Dr.  K.  A.  Smith  for  providing  affinity-purified  IL-2,  and  Kansai Medical 
Laboratory  Center,  Kyoto,  for  providing  the  chance  to  use  Spectrum  III.  We  also 
appreciate the assistance of Ms. Terumi Kobayashi in the preparation of the manuscript. 
Received for publication  21 March 1984 and in revised form 8 May 1984. 
Note  added  in  proof"  Recent  SDS-PAGE  analysis  of Tac  antigen  on  SAC- 
activated B cells revealed the same band (60-65 kD) as that of PHA-activated T 
cells. TSUDO  ET  AL.  BRIEF  DEFINITIVE  REPORT  617 
References 
1.  Uchiyama, T., S. Broder, and T. A. Waidmann. 1981. A monoclonal antibody (anti- 
Tac) reactive with activated and functionally mature human T cells. I. Production of 
anti-Tac monoclonal antibody and distribution of Tac (+) celis.J. Immunol.  126:1393. 
2.  Leonard, W. J., J. M. Depper, T. Uchiyama, K. A. Smith, T. A. Waldmann, and W. 
C. Green. 1982. A monoclonal antibody that appears to recognize the receptor for 
human T-cell growth factor: partial characterization of the receptor. Nature (Lond.). 
300:267. 
3.  Robb, R. J., and W. C. Green. 1983. Direct demonstration of the identity of T  cell 
growth factor binding protein and the Tac antigen. J. Exp. Med. 158:1332. 
4.  Robb,  R. J.,  A.  Munk,  and  K.  A.  Smith.  1981.  T  cell  growth  factor receptors. 
Quantitation, specificity, and biological relevance. J. Exp. Med. 154:1455. 
5.  Prakash, S., R. J. Robb, and D. C. Parker.  1982. Anti-Ig plus a culture supernatant 
from an IL-2-producing cloned T  cell hybridoma induces IL-2 receptors on Thy-1- 
negative cells. Fed. Proc. 41:304. (Abstr.) 
6.  Korsmeyer, S.J., W. C. Green,J. Cossman, Su-Ming Hsu,J. P.Jensen, L. M. Neckers, 
S.  L.  Marshall,  A.  Bakhshi, J.  M.  Depper, W. J.  Leonard, E. S. Jaffe, and T.  A. 
Waldmann.  1983.  Rearrangement and  expression of immunoglobulin  genes and 
expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA. 80:4522. 
7.  Muraguchi, A., and A. S.  Fauci.  1982. Proliferative responses of normal human B 
lymphocytes. Development of  an assay system for human B cell growth factor (BCGF). 
J. Immunol.  129:1104. 
8.  Oi, v. T., A. N. Glazer, and L. Stryer. 1982. Fluorescent phycobiliprotein conjugates 
for analysis of cells and molecules.J. Cell, Biol. 93:981. 
9.  Smith, K. A., M. F. Favata, and S. Oroszlan. 1983. Production and characterization 
of monoclonal antibodies to human interleukin 2: strategy and tactics. J. Immunol. 
131:1808. 
10.  Parker, D. C. 1982. Separable helper factors support B cell proliferation and matura- 
tion to Ig secretion. J. Immunol.  129:469. 
11.  Leibson, H. J., P. Marrack, and J. Kappler. 1982. B cell helper factors. II. Synergy 
among three helper factors in the response of T  cell- and macrophage-depleted B 
cells.J. Immunol.  129:1398. 
12.  Howard, M., L. Matis, T. R. Malek, E. Shevach, W. Kell, D. Cohen, K. Nakanishi, 
and W. E. Paul.  1983. Interleukin 2 induces antigen-reactive T  cell lines to secrete 
BCGF-I.J. Exp. Med.  158:2024. 
13.  Depper,J. M., W.J. Leonard, R.J. Robb, T. A. Waldmann, and W. C. Green. 1983. 
Blockade of the interleukin 2  receptor by anti-Tac antibody: inhibition of human 
lymphocyte activation. J. lmmunol.  131:690. 